開發中產品
R&D | Pilot Batch | Pivital Batch | BE Study | Submission | ||||
---|---|---|---|---|---|---|---|---|
多發性硬化症Orphan Drug(OEB 4) | ||||||||
威爾氏症Orphan Drug | ||||||||
毛囊炎High Potency (OEB 3) | ||||||||
肺纖維化High Potency (OEB 3) | ||||||||
潰瘍性結腸炎Sustained Release | ||||||||
器官移植抗排斥Sustained Release | ||||||||
黑色素瘤Anti-Cancer Drug (OEB 5) | ||||||||
黑色素瘤Anti-Cancer Drug (OEB 2) | ||||||||
轉甲狀腺素蛋白型心肌病Orphan Drug | ||||||||
維生素缺乏In-House API | ||||||||
骨質疏鬆High Potency (OEB 5) | ||||||||
焦慮症Controlled Substance | ||||||||
乾眼症Preservative-free | ||||||||
R&D | Pilot Batch | Pivital Batch | BE Study | Submission | ||||
---|---|---|---|---|---|---|---|---|
多發性硬化症 | Orphan Drug
(OEB 4) |
|||||||
威爾氏症 | Orphan Drug | |||||||
毛囊炎 | High Potency
(OEB 3) |
|||||||
肺纖維化 | High Potency
(OEB 3) |
|||||||
潰瘍性結腸炎 | Sustained Release | |||||||
器官移植抗排斥 | Sustained Release | |||||||
黑色素瘤 | Anti-Cancer Drug
(OEB 5) |
|||||||
黑色素瘤 | Anti-Cancer Drug
(OEB 2) |
|||||||
轉甲狀腺素蛋白型心肌病 | Orphan Drug | |||||||
維生素缺乏 | In-House API | |||||||
骨質疏鬆 | High Potency (OEB 5) |
|||||||
焦慮症 | Controlled Substance | |||||||
乾眼症 | Preservative-free | |||||||